drugset / Trial / NCT00264381
Management of Superficial Thrombophlebitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to test the hypothesis that Fragmin (dalteparin sodium) subcutaneously once daily for 7 days is more effective than Ibuprofen given orally three times daily for 7 days for the treatment of superficial thrombophlebitis (STP).
Timeline
- Start
- 2002-10
- Primary completion
- 2009-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dalteparin sodium | Other / unclassified | 10000 iu | Subcutaneous |